" class="no-js "lang="en-US"> PrecisionLife - Medtech Alert
Tuesday, September 23, 2025
PrecisionLife | Pharmtech Focus

PrecisionLife

About PrecisionLife

PrecisionLife

We focus on patients to reveal the complex personal biology of chronic diseases

Our unique combinatorial analytics are driving the next wave of precision medicine insights – finding new treatment opportunities for patients’ unmet medical needs in metabolic, inflammatory, respiratory, cardiovascular, women’s health, neurodegenerative and neuropsychiatric diseases.

Better understanding of complex disease biology –
We believe that deciphering the complex combinatorial influences on disease biology in patient sub-groups is at the heart of successful drug discovery and clinical development programs.

Accurately defining sub-groups of patients –
Our high-resolution stratification of populations and people enables us to understand disease risks and drivers, select the right patients for trials, and the right treatment for a patient.

New disease insights through collaboration –
We bring together data partners, charities, healthcare and life science companies, and Key Opinion Leaders to advance chronic disease outcomes.

We work with multi-disciplinary groups and organizations in disease collaborations to advance the understanding and treatment of chronic disease. Bring your data and expertise and work with our team and industry partners.

To find out more, visit our website https://precisionlife.com

Related Story

PrecisionLife Announces Appointment of Colin Stubberfield as SVP Drug Discovery to Lead Development of its Precision Medicine Programs

February 21 2022

PrecisionLife Limited, a global techbio company driving precision medicine in chronic diseases with drug discovery, […]

PrecisionLife Announces First Close of Series A Financing to Progress its Drug Discovery Pipeline and Commercial Partnerships

January 31 2022

PrecisionLife Limited, a global techbio company driving precision medicine in chronic disease with AI-led drug […]